Merck KGaA 1Q Net Profit Rose, Cuts 2020 View
May 14 2020 - 2:10AM
Dow Jones News
By Kim Richters
Merck KGaA said Thursday that net profit in its first quarter
rose, but it lowered its view for the year due to the coronavirus
pandemic.
The German pharmaceuticals and chemicals company had a net
profit of 456 million euros ($494.3 million) in the period, up from
EUR189 million a year earlier.
Net sales rose 16.7% to EUR4.37 billion, driven by all business
segments, Merck said.
The closely watched company metric Ebitda pre--or earnings
before interest, taxes, depreciation and amortization before
one-time items--was EUR1.18 billion for the quarter, up from EUR929
million a year ago.
Analysts had expected net sales of EUR4.18 billion and Ebitda
pre of EUR1.13 billion, according to consensus expectations
provided by Vara Research.
The pandemic had a "moderate" effect on business in 1Q, but it
expects this to increase in the next months, it said.
The company therefore lowered its 2020 view. It now expects a
slight to moderate organic increase in net sales to between EUR16.8
billion and EUR17.8 billion. It expects Ebitda pre to see a stable
organic development and be between EUR4.35 billion and EUR4.85
billion. It had previously guided for strong organic growth for
Ebitda pre and solid organic growth for sales.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
May 14, 2020 01:55 ET (05:55 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2023 to Apr 2024